• No results found

<p>Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura</p>

N/A
N/A
Protected

Academic year: 2020

Share "<p>Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura</p>"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 The mechanism of action of caplacizumab.Notes: (A) The pathogenesis of aTTP; the presence of anti-ADAMTS13 autoantibodies inhibits the proteolytic cleavage of ultra-large vwF multimers by ADAMTS13, which results in the aggregation of platelets thr
Table 1 The efficacy and safety data of both Phase II TITAN and Phase III HERCULES trials

References

Related documents

Percentage increase of university graduates in technical specializations, mathematics, natural sciences and technologies from the total number of graduate in 2004 compared to

Three simple, accurate and precise methods were developed for determination of fenoterol HBr I, salbutamol sulphate II and theophylline III in pure forms and in

Spectral characterization and examination of the potential antimicrobial and antioxidant activity of the synthesized complex were performed.. The imine Cu(II)

As the donor site problems is concerned, the work of Wei [23] done on fifteen patients reconstructed with bilateral radial free forearm flap after surgical release of sub

Results: Thematic content analysis of the interviews resulted in 6 major themes, including (1) Familiarity with medication safety &amp; adverse drug reaction concept (2) Current

BE: Bioequivalence; BW: Biowaiver; CD: Calendar days; CDDA: Cosmetics Devices and Drugs Authority; CDSCO: Central Drugs Standard Control Organization; CTD: Common technical

Deschauer M, Breunig F, Glocker FX, Vielhaber S, et al : Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2:

A small number of reports of rare, attenuated forms of CHS exist, with affected individuals exhibiting progressive neurodegenerative disease beginning in early adulthood with